Pegfilgrastim (Dompé Biotec)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePegfilgrastim (Dompé Biotec)
Drug Alias Name培非格司亭(Dompé Biotec)Neupopeg
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsNeutropenia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2002/08/22
Country/TerritoryEU
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesDompé Biotec
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDompe Farmaceutici Spa
Active IndicationsN/A
Inactive IndicationsNeutropenia

Other Information

ATC CodeL03AA13